McKesson Corporation (MCK)
| Market Cap | 94.00B |
| Revenue (ttm) | 377.60B |
| Net Income (ttm) | 3.16B |
| Shares Out | 124.38M |
| EPS (ttm) | 24.95 |
| PE Ratio | 30.29 |
| Forward PE | 19.02 |
| Dividend | $3.28 (0.43%) |
| Ex-Dividend Date | Sep 2, 2025 |
| Volume | 483,271 |
| Open | 752.28 |
| Previous Close | 750.13 |
| Day's Range | 744.00 - 756.36 |
| 52-Week Range | 486.77 - 776.14 |
| Beta | 0.51 |
| Analysts | Buy |
| Price Target | 827.18 (+9.45%) |
| Earnings Date | Nov 5, 2025 |
About MCK
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialt... [Read more]
Financial Performance
In 2024, McKesson's revenue was $359.05 billion, an increase of 16.22% compared to the previous year's $308.95 billion. Earnings were $3.30 billion, an increase of 9.76%.
Financial StatementsAnalyst Summary
According to 11 analysts, the average rating for MCK stock is "Buy." The 12-month stock price target is $827.18, which is an increase of 9.45% from the latest price.
News
How to trade the health care break out
The health care sector up 6.5% in one week. The Investment Committee debate how to trade the space.
See How McKesson Shares Rise with Money Flows
McKesson Corporation (MCK) shares up 138.5% since Big Money bought big in May 2022.
McKesson Corporation (MCK) Analyst/Investor Day Transcript
McKesson Corporation (NYSE:MCK) Analyst/Investor Day September 23, 2025 9:30 AM EDT Company Participants Brian Tyler - CEO & Director Britt Vitalone - Executive VP & CFO Kirk Kaminsky - President of ...
McKesson lifts annual profit forecast on plans to focus on high-margin businesses
McKesson on Tuesday raised its profit forecast, as the U.S. drug distributor aims to focus on high-margin businesses such as cancer medicines to boost growth.
McKesson Corporation Highlights Strategic Growth Strategies and Unveils Updated Long-term Financial Targets at Investor Day
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will host its 2025 Investor Day today, beginning at 9:30 AM ET. During the event, executive leadership will discuss the company's multi...
Drug distributor McKesson to restructure segments to focus on high-margin businesses
McKesson said on Thursday it will restructure its operations into four main segments from the current quarter as the U.S. drug distributor aims to focus on high-margin businesses such as cancer medici...
McKesson Announces New Organizational Structure
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) today announced changes to its reportable segments and organizational structure, effective in the second quarter of fiscal year 2026. T...
McKesson Corporation (MCK) Q1 2026 Earnings Call Transcript
McKesson Corporation (NYSE:MCK) Q1 2026 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants Brian S. Tyler - CEO & Director Britt J.
Mckesson lifts annual profit forecast on robust demand for specialty drugs
U.S. drug distributor McKesson raised its annual profit forecast and beat Wall Street earnings estimates on Wednesday, banking on robust demand for specialty medicines.
McKesson Corporation Reports Fiscal 2026 First Quarter Results and Raises Full Year Adjusted EPS Guidance
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2026 first quarter financial results. Results can be accessed on McKesson's Investor Relations website at inves...
McKesson Corporation Raises Quarterly Dividend by 15% to $0.82 Per Share
IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of $0.82 per share of common stock, a 15% increase from $0.71 per share ...
McKesson Defied The Doubters (Including Me)--And Could Do It Again
McKesson delivered strong double-digit growth in revenue, earnings, and free cash flow in fiscal 2025, outperforming the S&P 500 significantly. The planned spin-off of the underperforming Medical-Surg...
Our Top 10 High Growth Dividend Stocks - July 2025
The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rat...
McKesson ideaShare Empowers Independent Pharmacies to Innovate and Thrive
IRVING, Texas--(BUSINESS WIRE)--Last week, McKesson hosted more than 2,500 attendees representing independent pharmacies at the 2025 McKesson ideaShare conference in Nashville.
McKesson Corporation Announces First Quarter Fiscal 2026 Earnings Release Date
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2026 financial results after market close on Wednesday, August 6, 2025. The company will host a l...
Calls of the Day: ServiceNow, S&P Global, McKesson Corp., Ross Stores, TJX and Burlington
The Investment Committee debate the latest Calls of the Day.
Our Top 10 High Growth Dividend Stocks - June 2025
The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rat...
McKesson to Host Investor Day on September 23, 2025
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) announced it will host an Investor Day on Tuesday, September 23, 2025, in New York City. The event will feature presentations by McKess...
McKesson Corporation Completes Acquisition of Core Ventures
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) announced today that it has completed the acquisition of a controlling interest in Community Oncology Revitalization Enterprise Venture...
McKesson: Sustained Rally Backed By Strong Financials
The stock price of McKesson has maintained a strong upward trend throughout multiple years because of its solid financial performance and dedicated investor support which creates a defensive investmen...
Our Top 10 High-Growth Dividend Stocks -- May 2025
The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rat...
McKesson To Spin-Off Its Medical-Surgical Solutions Business
Deal OverviewOn May 8, 2025, McKesson Corporation (NYSE: MCK, $682.28, Market Capitalization: $85.4 billion), a diversified healthcare services company, announced its intention to separate its Medical...
McKesson Corporation (MCK) CFO Britt Vitalone Hosts BofA Securities 2025 Healthcare Conference (Transcript)
McKesson Corporation (NYSE:MCK) BofA Securities 2025 Healthcare Conference May 13, 2025 11:00 AM ET Company Participants Britt Vitalone - Chief Financial Officer Conference Call Participants Allen Lu...
McKesson: Spinoff Of Medical-Surgical Solutions Is A Positive, Strong Buy
I reiterate a Strong Buy rating on McKesson Corporation with a fair value of $828 per share, driven by robust growth in the oncology and biopharma sectors. McKesson posted 19% revenue growth and 63.8%...